Figure 1
From: Carfilzomib and the cardiorenal system in myeloma: an endothelial effect?
Change in NT-proBNP following treatment with carfilzomib (days 1 and 2).
Figure 1 | Blood Cancer Journal
From: Carfilzomib and the cardiorenal system in myeloma: an endothelial effect?
Change in NT-proBNP following treatment with carfilzomib (days 1 and 2).
